Skip to main content


Volume 410: debated on Friday 19 September 2003

The text on this page has been created from Hansard archive content, it may contain typographical errors.

To ask the Secretary of State for Trade and Industry what the turnover was of the biopharmaceuticals industry in (a) Speke Garston and (b) Greater Merseyside in 2002–03. [130434]

In August 2002, Merseyside had 14 biopharmaceutical companies with a turnover of £406 million for the period 2001–02. Specific figures for the Speke Garston area are not available, though the area has the highest concentration of biopharmaceuticals companies in the North West.